 | • レポートコード：B-GIR08C1241 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の世界市場について調べ、まとめました。種類別セグメントは、高リン血症管理、血中カルシウムレベル維持、PTHレベル管理、正しいアシドーシス、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他等に区分しました。慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の世界市場概観、企業動向、企業別慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の市場概観 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の企業別販売動向、市場シェア、市場集中度、競争動向 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の世界市場規模 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の北米市場分析（アメリカ、カナダ、メキシコ等） ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)のアメリカ市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)のカナダ市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)のメキシコ市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)のドイツ市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)のイギリス市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)のロシア市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の日本市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の中国市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の韓国市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)のインド市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の東南アジア市場規模推移 ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の南米市場分析（ブラジル、アルゼンチン等） ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の種類別分析/販売量、売上、市場シェア（高リン血症管理、血中カルシウムレベル維持、PTHレベル管理、正しいアシドーシス、その他） ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他） ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の販売チャネル・代理店・貿易業者・ディーラー分析 |
Chronic kidney disease mineral bone disorder (MBD) belongs to the bone disease pathology, is characterized by “inadequate bone mineralization” (bonemineralizationdeficiency), which is associated with chronic kidney disease of electrolyte and the direct result of endocrine disorder.
Scope of the Report:
The worldwide market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Akebia
Astellas
Shire
Vifor
Abbvie
Fresenius
Abbott
Novadiol
Japan Tobacco Company
Daiichi-Sankyo
Shield
Spectrum
OPKO
Ardelyx
Sanofi Genzyme
Amgen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Control Hyperphosphatemia
Maintain Blood Calcium Levels
Control PTH Level
Correct Acidosis
Other
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), with price, sales, revenue and global market share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in 2017 and 2018.
Chapter 3, the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Introduction
1.2 Market Analysis by Type
1.2.1 Control Hyperphosphatemia
1.2.2 Maintain Blood Calcium Levels
1.2.3 Control PTH Level
1.2.4 Correct Acidosis
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.3.4 Drug Stores
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Akebia
2.1.1 Business Overview
2.1.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Astellas
2.2.1 Business Overview
2.2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Shire
2.3.1 Business Overview
2.3.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Vifor
2.4.1 Business Overview
2.4.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbvie
2.5.1 Business Overview
2.5.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Fresenius
2.6.1 Business Overview
2.6.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Abbott
2.7.1 Business Overview
2.7.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Novadiol
2.8.1 Business Overview
2.8.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Japan Tobacco Company
2.9.1 Business Overview
2.9.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Daiichi-Sankyo
2.10.1 Business Overview
2.10.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Shield
2.11.1 Business Overview
2.11.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Spectrum
2.12.1 Business Overview
2.12.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 OPKO
2.13.1 Business Overview
2.13.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Ardelyx
2.14.1 Business Overview
2.14.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Sanofi Genzyme
2.15.1 Business Overview
2.15.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Amgen
2.16.1 Business Overview
2.16.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer Market Share in 2018
3.3.2 Top 6 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Analysis by Regions
4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Market Share by Regions
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Market Share by Regions (2014-2019)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Regions (2014-2019)
4.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
4.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
4.5 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
5 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
5.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Market Share by Country
5.1.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Market Share by Country (2014-2019)
5.1.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Country (2014-2019)
5.2 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
5.3 Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
5.4 Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
6 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
6.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Market Share by Country
6.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Market Share by Country (2014-2019)
6.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Country (2014-2019)
6.2 Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
6.3 UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
6.4 France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
6.5 Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
6.6 Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
7 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
7.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Country (2014-2019)
7.2 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
7.3 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
7.4 Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
7.5 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
8 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
8.1 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Market Share by Country
8.1.1 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Market Share by Country (2014-2019)
8.1.2 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Country (2014-2019)
8.2 Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
8.3 Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
8.4 Colombia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
9 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Countries
9.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
9.3 Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
9.4 Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
9.5 Nigeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
9.6 South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
10 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Segment by Type
10.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Market Share by Type (2014-2019)
10.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Type (2014-2019)
10.2 Control Hyperphosphatemia Sales Growth and Price
10.2.1 Global Control Hyperphosphatemia Sales Growth (2014-2019)
10.2.2 Global Control Hyperphosphatemia Price (2014-2019)
10.3 Maintain Blood Calcium Levels Sales Growth and Price
10.3.1 Global Maintain Blood Calcium Levels Sales Growth (2014-2019)
10.3.2 Global Maintain Blood Calcium Levels Price (2014-2019)
10.4 Control PTH Level Sales Growth and Price
10.4.1 Global Control PTH Level Sales Growth (2014-2019)
10.4.2 Global Control PTH Level Price (2014-2019)
10.5 Correct Acidosis Sales Growth and Price
10.5.1 Global Correct Acidosis Sales Growth (2014-2019)
10.5.2 Global Correct Acidosis Price (2014-2019)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2014-2019)
10.6.2 Global Other Price (2014-2019)
11 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Segment by Application
11.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Retail Pharmacies Sales Growth (2014-2019)
11.4 Online Pharmacies Sales Growth (2014-2019)
11.5 Drug Stores Sales Growth (2014-2019)
11.6 Other Sales Growth (2014-2019)
12 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
12.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Growth Rate (2019-2024)
12.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast by Regions (2019-2024)
12.2.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
12.2.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
12.2.3 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
12.2.4 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
12.2.5 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
12.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast by Type (2019-2024)
12.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Type (2019-2024)
12.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Forecast by Type (2019-2024)
12.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast by Application (2019-2024)
12.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Application (2019-2024)
12.4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Picture
Table Product Specifications of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure Global Sales Market Share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Types in 2018
Table Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Types for Major Manufacturers
Figure Control Hyperphosphatemia Picture
Figure Maintain Blood Calcium Levels Picture
Figure Control PTH Level Picture
Figure Correct Acidosis Picture
Figure Other Picture
Figure Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Figure Drug Stores Picture
Figure Other Picture
Figure United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (Value) and Growth Rate (2014-2024)
Table Akebia Basic Information, Manufacturing Base and Competitors
Table Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Vifor Basic Information, Manufacturing Base and Competitors
Table Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Fresenius Basic Information, Manufacturing Base and Competitors
Table Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novadiol Basic Information, Manufacturing Base and Competitors
Table Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Japan Tobacco Company Basic Information, Manufacturing Base and Competitors
Table Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Daiichi-Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shield Basic Information, Manufacturing Base and Competitors
Table Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Spectrum Basic Information, Manufacturing Base and Competitors
Table Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table OPKO Basic Information, Manufacturing Base and Competitors
Table OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ardelyx Basic Information, Manufacturing Base and Competitors
Table Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Genzyme Basic Information, Manufacturing Base and Competitors
Table Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type and Applications
Table Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturer (2017-2018)
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturer in 2017
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturer in 2018
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturer (2017-2018)
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Manufacturer in 2017
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Manufacturer in 2018
Figure Top 3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer (Revenue) Market Share in 2018
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2014-2019)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Regions (2014-2019)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Regions (2014-2019)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Regions (2014-2019)
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Regions (2014-2019)
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Regions in 2018
Figure North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2014-2019)
Table North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Countries (2014-2019)
Table North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Countries (2014-2019)
Figure North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Countries (2014-2019)
Figure North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Countries in 2018
Table North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Countries (2014-2019)
Table North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries (2014-2019)
Figure North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries (2014-2019)
Figure North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries in 2018
Figure United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2014-2019)
Table Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Countries (2014-2019)
Table Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Countries (2014-2019)
Table Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Countries (2014-2019)
Figure Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries (2014-2019)
Figure Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries in 2018
Figure Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Countries (2014-2019)
Table Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Countries 2018
Table Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Countries (2014-2019)
Figure Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries 2018
Figure China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2014-2019)
Table South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Countries (2014-2019)
Table South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Countries (2014-2019)
Figure South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Countries in 2018
Table South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Countries (2014-2019)
Table South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries (2014-2019)
Figure South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries in 2018
Figure Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Colombia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Countries (2014-2019)
Table Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Countries in 2018
Table Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Countries (2014-2019)
Table Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure UAE Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure Nigeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Figure South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2014-2019)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2014-2019)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Type (2014-2019)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2014-2019)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Type (2014-2019)
Figure Global Control Hyperphosphatemia Sales Growth (2014-2019)
Figure Global Control Hyperphosphatemia Price (2014-2019)
Figure Global Maintain Blood Calcium Levels Sales Growth (2014-2019)
Figure Global Maintain Blood Calcium Levels Price (2014-2019)
Figure Global Control PTH Level Sales Growth (2014-2019)
Figure Global Control PTH Level Price (2014-2019)
Figure Global Correct Acidosis Sales Growth (2014-2019)
Figure Global Correct Acidosis Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2014-2019)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Application (2014-2019)
Figure Global Retail Pharmacies Sales Growth (2014-2019)
Figure Global Online Pharmacies Sales Growth (2014-2019)
Figure Global Drug Stores Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Growth Rate (2019-2024)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Regions (2019-2024)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Forecast by Regions (2019-2024)
Figure North America Sales Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
Figure Europe Sales Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
Figure Asia-Pacific Sales Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
Figure South America Sales Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
Figure Middle East and Africa Sales Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast (2019-2024)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Type (2019-2024)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Forecast by Type (2019-2024)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Application (2019-2024)
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
全身性硬化症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Systemic sclerosis is a rare but serious autoimmune disease which causes hardening and swelling of the skin, as well as joint pain, digestive problems, lung disease, and sometimes problems with the heart and kidneys. Scope of the Report: The global Systemic Sclerosis Treatments market is valued at x…- 世界のクッシング病治療市場：市場規模・現状・予測 Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 急性片頭痛治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） A migraine is an episodic and unpredictable headache disorder that presents with disabling attacks. Treatment of a migraine attack should be guided by response to previous treatment and the severity of the attacks. Scope of the Report: The global Acute Migraine Treatments market is valued at xx mill…
- 世界のパニック障害市場：市場規模・現状・予測 Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks.Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used incl…
- 血圧障害薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Blood pressure disorder drug development technology and related units Scope of the Report: High blood pressure, also known as high blood pressure, is a condition in which arterial blood pressure continues to rise. Many factors affect blood pressure, including hormone levels in the body, water and sa…